The Heart That Wasn’t Attacked: A Case of Transverse Myelitis
Main Article Content
Downloads
Article Details
Copyright (c) 2018 Mokhtar MM, et al.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Krishnan C, Greenberg B (2016) Transverse myelitis. Link: https://goo.gl/E1mGgS
Chen L, Li J, Guo Z, Liao S, Jiang L (2013) Prognostic indicators of acute transverse myelitis in 39 children. Pediatr Neurol 49: 397-400. Link: https://goo.gl/oGskdU DOI: https://doi.org/10.1016/j.pediatrneurol.2013.08.022
Kaplin AI, Krishnan C, Deshpande DM, Pardo CA, Kerr DA (2005) Diagnosis and management of acute myelopathies. Neurologist 11: 2-18. Link: https://goo.gl/ok76Nd DOI: https://doi.org/10.1097/01.nrl.0000149975.39201.0b
Krishnan C, Kaplin AI, Pardo CA, Kerr DA, Keswani SC (2006) Demyelinating Disorders: update on transverse myelitis. Curr Neurol Neurosci Rep 6: 236-243. Link: https://goo.gl/jEgS2a DOI: https://doi.org/10.1007/s11910-006-0011-1
Jeffery DR, Mandler RN, Davis LE (1993) Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 50: 532-535. Link: https://goo.gl/CpQVfQ DOI: https://doi.org/10.1001/archneur.1993.00540050074019
Christensen PB, Wermuth L, Hinge HH, Bømers K (1990) Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand 81: 431-435. Link: https://goo.gl/xy4T4Q DOI: https://doi.org/10.1111/j.1600-0404.1990.tb00990.x
Scott TF, Frohman EM, De Seze J, Gronseth GS, Weinshenker BG (2011) Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 77: 2128-2134. Link: https://goo.gl/r1vrwN DOI: https://doi.org/10.1212/WNL.0b013e31823dc535
Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, et al. (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46: 878-886. Link: https://goo.gl/EqQoYd DOI: https://doi.org/10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q
Greenberg BM, Thomas KP, Krishnan C, Kaplin AI, Calabresi PA, et al. (2007) Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide. Neurology 68: 1614-1617. Link: https://goo.gl/7BHUw9 DOI: https://doi.org/10.1212/01.wnl.0000260970.63493.c8
Defresne P, Hollenberg H, Husson B, Tabarki B, Landrieu P, et al. (2003) Acute transverse myelitis in children: clinical course and prognostic factors. J Child Neurol 18: 401-406. Link: https://goo.gl/5cMvgy DOI: https://doi.org/10.1177/08830738030180060601
Bruna J, Martínez-Yélamos S, Martínez-Yélamos A, Rubio F, Arbizu T (2006) Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler 12: 169-173. Link: https://goo.gl/RRP7a1 DOI: https://doi.org/10.1191/135248506ms1260oa
Berman M, Feldman S, Alter M, Zilber N, Kahana E (1981) Acute transverse myelitis: incidence and etiologic considerations. Neurology 31: 966-971. Link: https://goo.gl/Hu9Yh6 DOI: https://doi.org/10.1212/WNL.31.8.966